Johnson & Johnson files for vaccine emergency use in PH

enablePagination: false
maxItemsPerPage: 10
maxPaginationLinks: 10

Johnson & Johnson has applied for emergency use of its single-dose COVID-19 vaccine in the Philippines.

Metro Manila (CNN Philippines, April 5) — US drugmaker Johnson & Johnson has applied for emergency use of its single-dose COVID-19 vaccine in the Philippines, Food and Drug Administration Director General Eric Domingo confirmed to CNN Philippines on Monday.

The vaccine, made by Belgium-based firm Janssen Pharmaceuticals, J&J's vaccine arm, was already authorized last month by the United States FDA for emergency use.

READ: Johnson & Johnson's Covid-19 vaccine gets emergency use authorization from US FDA 

Domingo said J&J applied for emergency use authorization of the vaccine in the country on Wednesday, March 31. Health Undersecretary Rosario Vergeire also confirmed the drugmaker's EUA application in a separate briefing.

Citing vaccine czar Carlito Galvez Jr., Presidential Spokesperson Harry Roque said the expected five million doses from the US drugmaker will be delivered by third quarter of the year.

"According to the earlier report of Secretary Galvez, ang J&J, at least from his last report to the President, is scheduled to arrive by third quarter specifically in the month of July," he said in his briefing on Monday.

TIMELINE: COVID-19 vaccine deliveries and rollout in the Philippines

Once authorized, J&J will be the fifth vaccine manufacturer in the country to get regulatory approval, following Pfizer-BioNTech, Oxford-AstraZeneca, Sinovac, and Gamaleya-Sputnik V.

American firms Moderna and Novovax have yet to apply for an EUA despite previously signing deals to deliver millions of doses to the country, which will be divided between the government and the private sector.